The role of Epigenetics in Kidney malignancies

Alfredo Harb-De la Rosa, Matthew Acker, Sanjaya Swain, Murugesan Manoharan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Introduction Renal cell carcinomas (RCC) are collectively the third most common type of genitourinary neoplasms, surpassed only by prostate and bladder cancer. Cure rates for renal cell carcinoma are related to tumor grade and stage; therefore, diagnostic methods for early detection and new therapeutic modalities are of paramount importance. Epigenetics can be defined as inherited modifications in gene expression that are not encoded in the DNA sequence itself. Epigenetics may play an important role in the pursuit of early diagnosis, accurate prognostication and identification of new therapeutic targets. Material and methods We used PubMed to conduct a comprehensive search of the English medical literature using search terms including epigenetics, DNA methylation, histone modification, microRNA regulation (miRNA) and RCC. In this review, we discuss the potential application of epigenetics in the diagnosis, prognosis and treatment of kidney cancer. Results During the last decade, many different types of epigenetic alterations of DNA have been found to be associated with malignant renal tumors. This has led to the research of the diagnostic and prognostic implications of these changes in renal malignancies as well as to the development of novel drugs to target these changes, with the aim of achieving a survival benefit. Conclusions Epigenetics has become a promising field in cancer research. The potential to achieve early detection and accurate prognostication in kidney cancer might be feasible through the application of epigenetics. The possibility to reverse these epigenetic changes with new therapeutic agents motivates researchers to continue pursuing better treatment options for kidney cancer and other malignancies.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalCentral European Journal of Urology
Volume68
Issue number2
DOIs
StatePublished - 2015

Fingerprint

Epigenomics
Kidney
Kidney Neoplasms
Neoplasms
Renal Cell Carcinoma
Histone Code
Urogenital Neoplasms
DNA Methylation
MicroRNAs
Research
PubMed
Urinary Bladder Neoplasms
Early Diagnosis
Prostatic Neoplasms
Therapeutics
Research Personnel
Gene Expression
DNA
Pharmaceutical Preparations

Keywords

  • DNA methylation
  • Histone modification
  • Kidney cancer
  • MicroRNA regulation

ASJC Scopus subject areas

  • Urology

Cite this

Harb-De la Rosa, A., Acker, M., Swain, S., & Manoharan, M. (2015). The role of Epigenetics in Kidney malignancies. Central European Journal of Urology, 68(2), 157-164. https://doi.org/10.5173/ceju.2015.453

The role of Epigenetics in Kidney malignancies. / Harb-De la Rosa, Alfredo; Acker, Matthew; Swain, Sanjaya; Manoharan, Murugesan.

In: Central European Journal of Urology, Vol. 68, No. 2, 2015, p. 157-164.

Research output: Contribution to journalArticle

Harb-De la Rosa, A, Acker, M, Swain, S & Manoharan, M 2015, 'The role of Epigenetics in Kidney malignancies', Central European Journal of Urology, vol. 68, no. 2, pp. 157-164. https://doi.org/10.5173/ceju.2015.453
Harb-De la Rosa, Alfredo ; Acker, Matthew ; Swain, Sanjaya ; Manoharan, Murugesan. / The role of Epigenetics in Kidney malignancies. In: Central European Journal of Urology. 2015 ; Vol. 68, No. 2. pp. 157-164.
@article{bd0d574ec0bc4343b6f1ddd972d667a8,
title = "The role of Epigenetics in Kidney malignancies",
abstract = "Introduction Renal cell carcinomas (RCC) are collectively the third most common type of genitourinary neoplasms, surpassed only by prostate and bladder cancer. Cure rates for renal cell carcinoma are related to tumor grade and stage; therefore, diagnostic methods for early detection and new therapeutic modalities are of paramount importance. Epigenetics can be defined as inherited modifications in gene expression that are not encoded in the DNA sequence itself. Epigenetics may play an important role in the pursuit of early diagnosis, accurate prognostication and identification of new therapeutic targets. Material and methods We used PubMed to conduct a comprehensive search of the English medical literature using search terms including epigenetics, DNA methylation, histone modification, microRNA regulation (miRNA) and RCC. In this review, we discuss the potential application of epigenetics in the diagnosis, prognosis and treatment of kidney cancer. Results During the last decade, many different types of epigenetic alterations of DNA have been found to be associated with malignant renal tumors. This has led to the research of the diagnostic and prognostic implications of these changes in renal malignancies as well as to the development of novel drugs to target these changes, with the aim of achieving a survival benefit. Conclusions Epigenetics has become a promising field in cancer research. The potential to achieve early detection and accurate prognostication in kidney cancer might be feasible through the application of epigenetics. The possibility to reverse these epigenetic changes with new therapeutic agents motivates researchers to continue pursuing better treatment options for kidney cancer and other malignancies.",
keywords = "DNA methylation, Histone modification, Kidney cancer, MicroRNA regulation",
author = "{Harb-De la Rosa}, Alfredo and Matthew Acker and Sanjaya Swain and Murugesan Manoharan",
year = "2015",
doi = "10.5173/ceju.2015.453",
language = "English (US)",
volume = "68",
pages = "157--164",
journal = "Central European Journal of Urology",
issn = "2080-4806",
publisher = "Panstwowy Zaklad Wydawnictw Lekarskich",
number = "2",

}

TY - JOUR

T1 - The role of Epigenetics in Kidney malignancies

AU - Harb-De la Rosa, Alfredo

AU - Acker, Matthew

AU - Swain, Sanjaya

AU - Manoharan, Murugesan

PY - 2015

Y1 - 2015

N2 - Introduction Renal cell carcinomas (RCC) are collectively the third most common type of genitourinary neoplasms, surpassed only by prostate and bladder cancer. Cure rates for renal cell carcinoma are related to tumor grade and stage; therefore, diagnostic methods for early detection and new therapeutic modalities are of paramount importance. Epigenetics can be defined as inherited modifications in gene expression that are not encoded in the DNA sequence itself. Epigenetics may play an important role in the pursuit of early diagnosis, accurate prognostication and identification of new therapeutic targets. Material and methods We used PubMed to conduct a comprehensive search of the English medical literature using search terms including epigenetics, DNA methylation, histone modification, microRNA regulation (miRNA) and RCC. In this review, we discuss the potential application of epigenetics in the diagnosis, prognosis and treatment of kidney cancer. Results During the last decade, many different types of epigenetic alterations of DNA have been found to be associated with malignant renal tumors. This has led to the research of the diagnostic and prognostic implications of these changes in renal malignancies as well as to the development of novel drugs to target these changes, with the aim of achieving a survival benefit. Conclusions Epigenetics has become a promising field in cancer research. The potential to achieve early detection and accurate prognostication in kidney cancer might be feasible through the application of epigenetics. The possibility to reverse these epigenetic changes with new therapeutic agents motivates researchers to continue pursuing better treatment options for kidney cancer and other malignancies.

AB - Introduction Renal cell carcinomas (RCC) are collectively the third most common type of genitourinary neoplasms, surpassed only by prostate and bladder cancer. Cure rates for renal cell carcinoma are related to tumor grade and stage; therefore, diagnostic methods for early detection and new therapeutic modalities are of paramount importance. Epigenetics can be defined as inherited modifications in gene expression that are not encoded in the DNA sequence itself. Epigenetics may play an important role in the pursuit of early diagnosis, accurate prognostication and identification of new therapeutic targets. Material and methods We used PubMed to conduct a comprehensive search of the English medical literature using search terms including epigenetics, DNA methylation, histone modification, microRNA regulation (miRNA) and RCC. In this review, we discuss the potential application of epigenetics in the diagnosis, prognosis and treatment of kidney cancer. Results During the last decade, many different types of epigenetic alterations of DNA have been found to be associated with malignant renal tumors. This has led to the research of the diagnostic and prognostic implications of these changes in renal malignancies as well as to the development of novel drugs to target these changes, with the aim of achieving a survival benefit. Conclusions Epigenetics has become a promising field in cancer research. The potential to achieve early detection and accurate prognostication in kidney cancer might be feasible through the application of epigenetics. The possibility to reverse these epigenetic changes with new therapeutic agents motivates researchers to continue pursuing better treatment options for kidney cancer and other malignancies.

KW - DNA methylation

KW - Histone modification

KW - Kidney cancer

KW - MicroRNA regulation

UR - http://www.scopus.com/inward/record.url?scp=84931828331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931828331&partnerID=8YFLogxK

U2 - 10.5173/ceju.2015.453

DO - 10.5173/ceju.2015.453

M3 - Article

AN - SCOPUS:84931828331

VL - 68

SP - 157

EP - 164

JO - Central European Journal of Urology

JF - Central European Journal of Urology

SN - 2080-4806

IS - 2

ER -